AADI Live signals | Maximize Profits with Getagraph.com

Live Chart Being Loaded With Signals

Commentary (31 May 2024 @ 16:00):

Stats
Today's Volume	184 218
Average Volume	291 741
Market Cap	44.20M
EPS	$0 ( 2024-05-08 )
Next earnings date	( $-0.640 ) 2024-06-11
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-0.710
ATR14	$0.00700 (0.39%)

Insider Trading

Date	Person	Action	Amount	type
2024-05-01	Desai Neil	Sell	40 000	Common Stock
2024-04-23	Ball Bryan	Sell	0	Common Stock
2024-04-23	Ball Bryan	Sell	147 500	Stock option (right to buy)
2024-04-23	Ball Bryan	Sell	50 000	Stock option (right to buy)
2024-04-23	Ball Bryan	Sell	40 000	Stock option (right to buy)

INSIDER POWER
43.30
Last 94 transactions
Buy: 5 312 775 \| Sell: 1 045 050

Volume Correlation

Long: 0.08 (neutral)

Short: -0.51 (weak negative)

Signal:(51.187) Neutral

Aadi Bioscience, Inc. Correlation

10 Most Positive Correlations
OZEM	1
EVCGX	0.885
BUJA	0.879
NBBK	0.874
BDGS	0.868
MCHFX	0.861
MICFX	0.861
MSAQX	0.861
AITR	0.858
FHKCX	0.858

10 Most Negative Correlations
BRLSW	-0.864
PTLO	-0.863
CLMB	-0.858
IIMFX	-0.855
RDZN	-0.853
APLM	-0.851
RENB	-0.846
FATBB	-0.841
BTCT	-0.836
NAAS	-0.835

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Aadi Bioscience, Inc. Correlation - Currency/Commodity

0.78
( moderate )

0.68
( moderate )

0.00
( neutral )

0.74
( moderate )

-0.79
( moderate negative )

Aadi Bioscience, Inc. Financials

Annual	2023
Revenue:	$24.35M
Gross Profit:	$21.55M (88.47 %)
EPS:	$-2.44

FY	2023
Revenue:	$24.35M
Gross Profit:	$21.55M (88.47 %)
EPS:	$-2.44

FY	2022
Revenue:	$15.22M
Gross Profit:	$13.88M (91.23 %)
EPS:	$-2.53

FY	2021
Revenue:	$1.00M
Gross Profit:	$0.00 (0.00 %)
EPS:	$-12.41

Financial Reports:

No articles found.

Aadi Bioscience, Inc. Options Data

Calls

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Puts

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Aadi Bioscience, Inc.

Aadi Bioscience, Inc., a clinical-stage biopharmaceutical company, engages in developing and commercializing precision therapies for genetically defined cancers with alterations in mTOR pathway genes. Its lead drug candidate, FYARRO is a form of sirolimus bound to albumin. Aadi is evaluating FYARRO in cancers with known mTOR pathway activation, including tumor agnostic indications targeting specific genomic alterations that activate the mTOR pathway. The company was incorporated in 2007 and is headquartered in Pacific Palisades, California.